370 related articles for article (PubMed ID: 1346818)
1. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.
Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A
Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
3. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
[TBL] [Abstract][Full Text] [Related]
4. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
[TBL] [Abstract][Full Text] [Related]
5. Bettering BCG.
Lancet; 1992 Feb; 339(8791):462-3. PubMed ID: 1346823
[No Abstract] [Full Text] [Related]
6. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
[TBL] [Abstract][Full Text] [Related]
7. Vaccination and skin test studies on the children of leprosy patients.
Stanford JL; Stanford CA; Ghazi Saidi K; Dowlati Y; Weiss SF; Farshchi Y; Madlener F; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):38-44. PubMed ID: 2659700
[TBL] [Abstract][Full Text] [Related]
8. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
[TBL] [Abstract][Full Text] [Related]
9. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of three potential vaccines for leprosy in Bombay.
Ganapati R; Revankar CR; Lockwood DN; Wilson RC; Price JE; Ashton P; Ashton LA; Holmes RM; Bennett C; Stanford JL
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):33-7. PubMed ID: 2659699
[TBL] [Abstract][Full Text] [Related]
11. Sensitization studies with potential leprosy vaccine preparations in northern Malawi.
Ponnighaus JM; Fine PE
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):25-37. PubMed ID: 3519803
[TBL] [Abstract][Full Text] [Related]
12. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
[TBL] [Abstract][Full Text] [Related]
13. Protective immunization of monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: clinical results.
Gormus BJ; Baskin GB; Xu K; Bohm RP; Mack PA; Ratterree MS; Cho SN; Meyers WM; Walsh GP
Lepr Rev; 1998 Mar; 69(1):6-23. PubMed ID: 9628092
[TBL] [Abstract][Full Text] [Related]
14. rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B.
Gillis TP; Tullius MV; Horwitz MA
Infect Immun; 2014 Sep; 82(9):3900-9. PubMed ID: 25001602
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice.
Shepard CC; van Landingham RM; Walker LL; Ye SZ
Infect Immun; 1983 Jun; 40(3):1096-103. PubMed ID: 6343239
[TBL] [Abstract][Full Text] [Related]
16. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of mice against Mycobacterium leprae infection.
Singh NB; Lowe AC; Rees RJ; Colston MJ
Infect Immun; 1989 Feb; 57(2):653-5. PubMed ID: 2643581
[TBL] [Abstract][Full Text] [Related]
18. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
De Britto RL; Ramanathan VD; Gupte MD
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
[TBL] [Abstract][Full Text] [Related]
19. The Karonga Prevention Trial: a leprosy and tuberculosis vaccine trial in northern Malaŵi. I. Methods of the vaccination phase.
Pönnighaus JM; Fine PE; Bliss L; Gruer PJ; Kapira-Mwamondwe B; Msosa E; Rees RJ; Clayton D; Pike MC; Sterne JA
Lepr Rev; 1993 Dec; 64(4):338-56. PubMed ID: 8127221
[TBL] [Abstract][Full Text] [Related]
20. Immunological cytokine correlates of protective immunity and pathogenesis in leprosy.
Lima MC; Pereira GM; Rumjanek FD; Gomes HM; Duppre N; Sampaio EP; Alvim IM; Nery JA; Sarno EN; Pessolani MC
Scand J Immunol; 2000 Apr; 51(4):419-28. PubMed ID: 10736116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
